iSOFT Launches Web-Based E-Prescribing Solution for the NHS

iSOFT Group LimitediSOFT Group Limited (ASX:ISF) has launched a new e-prescribing and medication administration (ePMA) solution in the UK and is close to finalising deals with a number of NHS trusts to become early adopters.

The solution is already used at ten hospitals in Australia and across six district health boards in New Zealand for safer and more efficient medicines management. Users report sharp falls in incidents due to drugs being wrongly prescribed or doses being missed. And incidents due to illegible scripts are a thing of the past.

Working with First DataBank, a leading provider of drug databases and active clinical decision support, iSOFT has adapted the solution for the UK market. It offers a drug formulary and decision support rules engine to stop drugs being wrongly prescribed and so shorten hospital stays. It will also streamline processes such as discharge, reduce re-admission rates, and cut costs.

"We have a very strong, if not unique, proposition in combining the scale and capability of iSOFT to deliver a best of breed ePMA solution," said Adrian Stevens, Managing Director of iSOFT's UK and Ireland business.

"This is also very timely following the recent publication of the UK government's white paper, Equity and Excellence: Liberating the NHS, which highlights the importance of improving healthcare outcomes and patient safety.

"Last year, the National Patient Safety Agency reported that more than 200 patients every month need further treatment or die because of medication mistakes. Our ePMA solution can help to drastically reduce this statistic."

The solution is specifically designed to allow NHS trusts that have already invested in elements of an electronic patient record to introduce a fully integrated and comprehensive ePMA solution.

Mark Treleaven, Sales and Marketing Director, First DataBank said: "It is clear that iSOFT's new solution has been designed to meet the specialist requirements of prescribing and administering medicines. As such, we are very excited to see our product associated with an initiative that will make full use of the Multilex DDF sophistication."

The first early adopter sites are expected to go-live in 2011. The software will be exhibited at various events throughout the year including E-Health Insider Live in November.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 countries worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...